Dr. Gavin W. Britz MD, MPH, FAANS is a Professor and Chairman of the Department of Neurosurgery at Houston Methodist Hospital and Co-Director of the Methodist Neurological Institute. He leads an acclaimed team of neurosurgeons and affiliated professionals and he is recognized as one of the nation’s foremost Cerebrovascular, skull base and brain tumor surgeons. He is one of the most experienced surgeons for brain aneurysm procedures; including highly complex cases that require cardiac standstill or complex bypasses. He treats brain Aneurysms using the traditional microsurgical techniques but also performs Endovascular treatment with coiling and stenting of aneurysms as he has been trained in both Neurosurgery and Interventional neuroradiology.

Prior to this, he was at Duke University Medical Center in North Carolina where he served as Director of the Cerebrovascular Center and Associate Professor of Neurosurgery. Earlier in his career, he was Co-Director of the Neurological Surgery Unit and Director of Endovascular Neurosurgery at Harborview Medical Center while serving as Associate Professor of Neurosurgery and Radiology at The University of Washington School of Medicine in Seattle. He has received Best Doctor in America distinction in six different years. He is on the Advisory boards of the Joe Niekro Foundation and The Brain Aneurysm Foundation. He serves on the Editorial board for Neurosurgery, World Neurosurgery, International Journal of Vascular Medicine, Surgical Neurology International, Dataset Papers in Medicine and SOJ Neurology. He has authored more than 100 peer reviewed scientific manuscripts and 29 chapters for various neurosurgical books and author of 2 textbooks related to neurosurgery. The brain tumors include tumors such as meningiomas; chordomas; pituitary tumors; craniopharyngiomas; vestibular schwannomas; gliomas; and glioblastomas. He also performs microvascular decompressions for facial pain and hemifacial spasm. He leads basic science and clinical studies to understand stroke causation and evaluates novel tools to treat brain aneurysms and skull base tumors.

Arteriovenous malformations; Dural fistulas; Arterial dissections; Atherosclerotic disease; Moyamoya disease; Diseases affecting the skull base and brain tumors.